
Archit Organosys Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-05-19 08:01:39Archit Organosys Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a recent price correction and evolving market dynamics, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks.
Read MoreBoard Meeting Intimation for Consider And Approve The Unaudited Financial Results Of The Company For The Quarter Ended On June 30 2026
07-Aug-2026 | Source : BSEArchit Organosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended on June 30 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Jul-2026 | Source : BSECompliance certificate under Reg 74(5) of SEBI (DP) Regulations2018 for Quarter June 2026.
Closure of Trading Window
25-Jun-2026 | Source : BSEIntimation for Closure of Trading Window for the quarter ended 30th June 2026
Corporate Actions
12 Aug 2026
Archit Organosys Ltd has declared 5% dividend, ex-date: 22 Sep 25
No Splits history available
No Bonus history available
Archit Organosys Ltd has announced 2:1 rights issue, ex-date: 09 Feb 17